The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study

Immune checkpoint inhibitors (ICIs) have been approved to treat patients with various cancer types, including lung cancer, in many countries. This study aims to investigate the effectiveness and safety of ICIs under different treatment conditions of non-small cell lung cancer patients. A population-...

Full description

Bibliographic Details
Main Authors: Jason C. Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, Szu-Chun Yang, Chien-Chung Lin, Yi-Hsin Yang, Yu-Chao Lin, Te-Chun Hsia, Hsing-Chun Hsieh, Jia-Syuan Wu, Chi-Pei Chang, Yin-Hsun Feng, Peng-Chan Lin, Ping-Chih Hsu, Huey-En Tzeng, Shu-Chen Chien, Wei-Chiao Chang, Chih-Cheng Chang, Hsuan-Chia Yang, Chueh Ming Lee, Christine Y. Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
effectiveness
immune checkpoint inhibitors (ICI)
non-small-cell lung cancer (NSCLA)
observational study
Taiwan
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671127/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.671127/full

Similar Items